| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 239.19M | 212.88M | 218.00M | 168.82M | 175.41M |
| Gross Profit | 183.89M | 138.19M | 137.99M | 116.51M | 124.06M |
| EBITDA | 183.09M | 123.89M | 126.73M | 106.32M | 119.94M |
| Net Income | 98.76M | 119.42M | 123.38M | 105.48M | 119.81M |
Balance Sheet | |||||
| Total Assets | 2.66T | 2.63B | 2.47B | 2.59B | 2.57B |
| Cash, Cash Equivalents and Short-Term Investments | 55.76B | 53.52M | 49.40M | 59.78M | 117.42M |
| Total Debt | 0.00 | 1.39B | 1.26B | 1.39B | 1.41B |
| Total Liabilities | 1.55T | 1.49B | 1.34B | 1.48B | 1.47B |
| Stockholders Equity | 1.12T | 1.14B | 1.14B | 1.12B | 1.10B |
Cash Flow | |||||
| Free Cash Flow | 126.75M | 112.58M | 125.87M | 114.21M | 54.49M |
| Operating Cash Flow | 126.75M | 112.58M | 125.87M | 114.21M | 54.49M |
| Investing Cash Flow | -97.23M | -139.68M | 93.40M | -431.04M | 211.06M |
| Financing Cash Flow | -71.88M | 14.25M | -231.43M | 238.33M | -138.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $814.75M | 8.24 | 8.75% | 13.18% | -26.08% | -27.65% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $1.03B | 8.89 | 7.96% | 17.34% | -16.58% | 65.24% | |
61 Neutral | $805.44M | 58.66 | 1.30% | 14.17% | 36.15% | -38.59% | |
60 Neutral | $785.93M | 10.97 | 6.74% | 13.63% | -8.23% | -35.72% | |
58 Neutral | $807.95M | 8.73 | 9.31% | 10.80% | -6.30% | -6.92% | |
54 Neutral | $815.57M | 23.58 | 3.44% | 13.64% | 36.91% | -48.79% |
On February 26, 2026, Bain Capital Specialty Finance reported strong fourth-quarter and full-year 2025 results, with net investment income of $0.46 per share and net income of $0.43 per share, supporting an annualized return on book value near 10%. The company’s net asset value per share stood at $17.23 as of December 31, 2025, while non-accruals remained low at 1.5% of the portfolio at cost, underscoring solid credit quality across its $2.51 billion, 203-company investment book.
The board declared a regular first-quarter 2026 dividend of $0.42 per share for shareholders of record on March 16, 2026, following special dividends totaling $0.18 per share declared in the fourth quarter. Bain Capital Specialty Finance also refinanced part of its balance sheet by issuing $350 million of 5.95% unsecured notes due 2031 on January 29, 2026, using the proceeds to repay secured debt and bolster financial flexibility, while maintaining a net debt-to-equity ratio of 1.24x amid modest net portfolio contraction.
The most recent analyst rating on (BCSF) stock is a Hold with a $14.50 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.
On January 29, 2026, Bain Capital Specialty Finance, Inc. entered into a Fourth Supplemental Indenture with U.S. Bank Trust Company, National Association, covering the issuance of $350 million in 5.950% notes due March 1, 2031, which were sold in a registered offering that closed the same day. The notes, general unsecured obligations ranking senior to subordinated debt and pari passu with other unsecured unsubordinated obligations, carry semi-annual interest payments starting September 1, 2026, include change-of-control repurchase protections and Investment Company Act-related asset coverage covenants, and generated approximately $342.5 million in net proceeds that the company plans to use to repay outstanding secured indebtedness under its financing arrangements and for general corporate purposes, effectively extending its debt maturity profile and shifting its capital structure toward more unsecured funding.
The most recent analyst rating on (BCSF) stock is a Hold with a $15.00 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.
On January 22, 2026, Bain Capital Specialty Finance, Inc. entered into an underwriting agreement with BCSF Advisors, LP and a syndicate of underwriters led by Wells Fargo Securities, J.P. Morgan Securities, and SMBC Nikko Securities America to issue and sell $350 million of 5.950% notes due 2031. The transaction, conducted under the company’s existing shelf registration, adds a sizable tranche of long-dated, fixed-rate debt to its capital structure, reinforcing its funding base and potentially supporting future lending activity, while customary indemnification and covenant provisions align with standard market practice and help manage legal and underwriting risks for all parties involved.
The most recent analyst rating on (BCSF) stock is a Buy with a $15.50 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.
On December 22, 2025, Bain Capital Specialty Finance, Inc. announced that its board had declared a special cash dividend of $0.15 per share, to be paid on January 26, 2026, to shareholders of record as of December 31, 2025. The company said the special distribution, driven by over-earnings during the year, is intended to help manage its tax and regulated investment company distribution requirements, while supporting disciplined capital management and maintaining spillover income to underpin the stability of its regular dividend and the gradual growth of net asset value per share over time.
The most recent analyst rating on (BCSF) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Bain Capital Specialty Finance stock, see the BCSF Stock Forecast page.